Metabolite profiles of flutamide in serum from patients with flutamide-induced hepatic dysfunction

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 10, 2003, Pages 1455-1460

  Takashima, Eiji ^a   Iguchi, Kazuhiro ^a   Usui, Shigeyuki ^a   Yamamoto, Hajime ^b   Hirano, Kazuyuki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Flutamide; Hepatotoxicity; Metabolite profile; Risk prediction; Serum

Indexed keywords

FLUTAMIDE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; ION MONITORING; LIQUID CHROMATOGRAPHY; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TOXICITY; MALE; MASS SPECTROMETRY; OXIDATION; PROSTATE CANCER; RISK ASSESSMENT; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; LIVER DISEASE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; FLUTAMIDE; HUMANS; LIVER DISEASES; MIDDLE AGED;

EID: 1542541346     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.1455     Document Type: Article

References (24)

1. Neri R., Florance K., Koziol P., Van Cleave S., Endocrinology, 91, 427-437 (1972).
2. Stoliar B., Albert D. J., J. Urol., 111, 803-807 (1974).
3. Neri R., Peets E., Watnick A., Biochem. Soc. Trans., 7, 565-569 (1979).
4. Labrie F., Dupont A., Cusan L., Manhes G., Bergeron N., Lacourciere Y., Pineault S., Belanger A., Monfette G., Emond J., J. Steroid Biochem., 33, 817-821 (1989).
5. Crawford E. D., Eisenberger M. A., McLeod D. G., Spaulding J. T., Benson R., Dorr F. A., Blumenstein B. A., Davis M. A., Goodman P. J., N. Engl. J. Med., 321, 419-424 (1989).
6. Caubet J. F., Tosteson T. D., Dong E. W., Naylon E. M., Whiting G. W., Ernstoff M. S., Ross S. D., Urology, 49, 71-78 (1997).
7. Cusan L., Dupont A., Belanger A., Tremblay R. R., Manhes G., Labrie F., J. Am. Acad. Dermatol., 23, 462-469 (1990).
8. Caine M., Perlberg S., Gordon R., J. Urol., 114, 564-568 (1975).
9. Wysowski D. K., Fourcroy J. L., J. Urol., 155, 209-212 (1996).
10. Gomez J. L., Dupont A., Cusan L., Tremblay M., Suburu R., Lemay M., Labrie F., Am. J. Med., 92, 465-470 (1992).
11. Nakagawa Y., Koyama M., Matsumoto M., Hinyokika Kiyo, 45, 821-826 (1999).
12. Wada T., Ueda M., Abe K., Kobari T., Yamazaki H., Nakata J., Ikemoto I., Ohishi Y., Aizawa Y., Hinyokika Kiyo, 45, 521-526 (1999).
13. Akaza H., Usami M., Kotake T., Koiso K., Aso Y., Jpn. J. Clin. Oncol., 23, 178-185 (1993).
14. Berson A., Wolf C., Chachaty C., Fisch C., Fau D., Eugene D., Loeper J., Gauthier J. C., Beaune P., Pompon D., Maurel P., Pessayre D., J. Pharmacol. Exp. Ther., 265, 366-372 (1993).
15. Fau D., Eugene D., Berson A., Letteron P., Fromenty B., Fisch C., Pessayre D., J. Pharmacol. Exp. Ther., 269, 954-962 (1994).
16. Berson A., Wolf C., Berger V., Fau D., Chachaty C., Fromenty B., Pessayre D., J. Pharmacol. Exp. Ther., 257, 714-719 (1991).
17. Cicognani C., Malavolti M., Morselli-Labate A. M., Sama C., Barbara L., Dig. Dis. Sci., 41, 2219-2221 (1996).
18. Kojima M., Kamoi K., Ukimura O., Fujito A., Nakao M., Tanaka S., Miyashita H., Iwamoto N., Ohe H., Kitamori T., Date S., Kitamura K., Araki H., Aoki T., Imada N., Takada H., Imaide Y., Mikami K., Uchida M., Saitoh M., Miki T., Int. J. Urol., 9, 42-46 (2002).
19. Guengerich F. P., Kim D. H., Iwasaki M., Chem. Res. Toxicol., 4, 168-179 (1991).
20. Koop D. R., FASEB J., 6, 724-730 (1992).
21. Ichikawa E., Hara K., Matsuzaki Y., Doi M., Kanzou, 40, 227-234 (1999).
22. Nunez-Vergara L. J., Farias D., Bollo S., Squella J. A., Bioelectrochemistry, 53, 103-110 (2001).
23. Ozono S., Yamaguchi A., Mochizuki H., Kawakami T., Fujimoto K., Otani T., Yoshida K., Ichinei M., Yamashita T., Hirao Y., Prostate Cancer Prostatic Dis., 5, 128-131 (2002).
24. Wang H. X., Ma X. C., Deng Q. L., Li D., Acta Pharmacol. Sin., 23, 562-566 (2002).